Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP-Reference-Cited by-同舟云学术

Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP

Published:1999-09 Issue:6749 Volume:401 Page:173-177
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Yeung Kam,Seitz Thomas,Li Shengfeng,Janosch Petra,McFerran Brian,Kaiser Christian,Fee Frances,Katsanakis Kostas D.,Rose David W.,Mischak Harald,Sedivy John M.,Kolch Walter

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/43686.pdf

Reference26 articles.

1. Ferrell, J. E. Jr MAP kinases in mitogenesis and development. Curr. Top. Dev. Biol. 33, 1–60 (1996).

2. Morrison,D. K. & Cutler,R. E. The complexity of Raf-1 regulation. Curr. Opin. Cell Biol. 9, 174–179 (1997).

3. Moodie,S. A., Willumsen,B. M., Weber,M. J. & Wolfman,A. Complexes of Ras/GTP with Raf-1 and mitogen-activated protein kinase kinase. Science 260, 1658–1661 (1993).

4. Schaeffer,H. J. et al. MP1: A MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science 281, 1668–1671 (1998).

5. Bruder,J. T., Heidecker,G. & Rapp,U. R. Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase. Genes Dev. 6, 545–556 (1992).

Cited by 750 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetically predicted metabolites mediate the association between lipidome and malignant melanoma of skin;Frontiers in Oncology;2024-09-10

2. MEK inhibitors: a promising targeted therapy for cardiovascular disease;Frontiers in Cardiovascular Medicine;2024-07-01

3. MEK inhibitors and DA‐Raf, a dominant‐negative antagonist of the Ras–ERK pathway, prevent the migration and invasion of KRAS‐mutant cancer cells;Cytoskeleton;2024-06-14

4. 15-Lipoxygenase-Mediated Lipid Peroxidation Regulates LRRK2 Kinase Activity;2024-06-13

5. Raf kinase inhibitor protein expression in smooth muscle tumours of the uterus: a diagnostic marker for leiomyosarcoma?;Reproductive BioMedicine Online;2024-06